Broadwood Partners, L.P.

10% OwnerOncocyte Corp (OCX) · full profile →Form 4 · filed Feb 10, 2025
Net Buying
Open-Market Buys
$10.6M
Open-Market Sells
$0
Net Open-Market Flow
$10.6M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2025Buy(P)0$011.4M
Feb 6, 2025Buy(P)0$06.9M
Feb 6, 2025Buy(P)660K$2.05$1.4M6.9M
Feb 6, 2025Buy(P)4.5M$2.05$9.2M11.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000919574-25-000922) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about OCX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000919574-25-000922"
Ask your agent
Use Arkolith to summarize insider buying and selling at Oncocyte Corp
over the last 90 days and cite the filings.